Showing results (491-500 of 542) with videos related to
Sort By:
Pageof 55
Nature Communications|February 1, 2020
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infectionValeria Barili, Paola Fisicaro, Barbara Montanini, et al.Gut|July 12, 2014
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in CaucasiansPauline Arends, Milan J Sonneveld, Roeland Zoutendijk, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2017
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programmeChristophe Hézode, Pascal Lebray, Victor De Ledinghen, et al.Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.Hepatology (Baltimore, Md.)|March 7, 2022
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translationRomain Barnault, Claire Verzeroli, Carole Fournier, et al.Journal of Hepatology|June 6, 2026
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis BCamilla Ceccatelli Berti, Ilaria Montali, Sara Doselli, et al.Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived OrganoidsMario Cioce, Maria Rita Fumagalli, Sara Donzelli, et al.Journal of Hepatology|June 21, 2019
Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesisMarc Bonnin, Nadim Fares, Barbara Testoni, et al.The New England Journal of Medicine|June 6, 2024
Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis DTarik Asselah, Vladimir Chulanov, Pietro Lampertico, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.Pageof 55